- Section 1 - About the Company
- Viridian Therapeutics Inc - Key Facts
- Viridian Therapeutics Inc - Key Employees
- Viridian Therapeutics Inc - Key Employee Biographies
- Viridian Therapeutics Inc - Major Products and Services
- Viridian Therapeutics Inc - History
- Viridian Therapeutics Inc - Company Statement
- Viridian Therapeutics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Viridian Therapeutics Inc - Business Description
- R&D Overview
- Viridian Therapeutics Inc - Corporate Strategy
- Viridian Therapeutics Inc - SWOT Analysis
- SWOT Analysis - Overview
- Viridian Therapeutics Inc - Strengths
- Viridian Therapeutics Inc - Weaknesses
- Viridian Therapeutics Inc - Opportunities
- Viridian Therapeutics Inc - Threats
- Viridian Therapeutics Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
- Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
- Viridian Therapeutics Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Feb 16, 2024: Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer
- Jan 08, 2024: Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
- Oct 30, 2023: Viridian Therapeutics Appoints New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs and Announces $185 Million Private Placement Financing
- Sep 25, 2023: Viridian Appoints Sarah Gheuens, M.D., Ph.D., to its Board of Directors
- Sep 08, 2023: Viridian Therapeutics : Appointments
- May 09, 2023: Viridian Therapeutics reports first quarter 2023 financial results and provides corporate update
- Apr 12, 2023: Viridian Therapeutics : Departure of Directors or Certain Officers
- Mar 01, 2023: Viridian Therapeutics to Webcast Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
- Feb 06, 2023: Viridian Appoints Scott Myers as President and Chief Executive Officer
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Viridian Therapeutics Inc, Key Facts
- Viridian Therapeutics Inc, Key Employees
- Viridian Therapeutics Inc, Key Employee Biographies
- Viridian Therapeutics Inc, Major Products and Services
- Viridian Therapeutics Inc, History
- Viridian Therapeutics Inc, Subsidiaries
- Viridian Therapeutics Inc, Key Competitors
- Viridian Therapeutics Inc, Ratios based on current share price
- Viridian Therapeutics Inc, Annual Ratios
- Viridian Therapeutics Inc, Annual Ratios (Cont...1)
- Viridian Therapeutics Inc, Interim Ratios
- Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
- Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
- Viridian Therapeutics Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Viridian Therapeutics Inc, Performance Chart (2019 - 2023)
- Viridian Therapeutics Inc, Ratio Charts
- Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
- Viridian Therapeutics Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook